Stevanato Group (NYSE:STVN) stock has attracted attention lately, trading at $25.86 as of the last close. Investors seem curious about how current valuation compares with the company’s steady financial performance throughout this year.
Stevanato Group has picked up notable momentum lately, registering a 5.81% 1-day share price return and climbing 10.94% over the past week. This signals renewed investor confidence. Even with some ups and downs in recent months, the company’s 1-year total shareholder return of 42.48% stands out. This suggests that long-term growth potential is drawing positive attention.
If today’s action has you wondering what other opportunities are out there, it’s a great time to broaden your investing horizons and discover fast growing stocks with high insider ownership
But with shares now hovering close to analysts’ price targets, the key question emerges: is Stevanato Group stock currently undervalued, or has the market already priced in its anticipated growth?
Most Popular Narrative: 9.6% Undervalued
Stevanato Group’s fair value is pegged at $28.62 by the most popular narrative, coming in above the latest price of $25.86. There is clear bullishness driving this target, rooted in powerful industry catalysts and bold optimism about Stevanato’s earnings runway.
Rising pharmaceutical industry investment in U.S. onshoring and manufacturing capacity creates a structural tailwind for Stevanato’s North American operations, particularly at the new Fishers facility. This enhances supply chain localization, deepens client relationships, and is expected to materially contribute to future top-line growth and operating margins as these plants scale up.
What is the secret sauce behind this price target? The narrative assumes Stevanato transforms pharma supply chains and boosts margins with rapid growth in next-generation manufacturing. Which key numbers unlock this premium? You will need to see the full narrative to find out.
Result: Fair Value of $28.62 (UNDERVALUED)
However, persistent high capital expenditure or unexpected setbacks at new facilities could challenge margin expansion and delay Stevanato’s anticipated growth trajectory.
Another View: Is the Valuation Too High?
Our DCF model, which projects the company’s future cash flows, arrives at a fair value of $11.33. This is well below today’s share price. This approach points to Stevanato Group being overvalued at current levels. Could the market be too optimistic about future growth, or is there something the model is missing?
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Stevanato Group for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover undervalued stocks based on their cash flows. If you save a screener we even alert you when new companies match – so you never miss a potential opportunity.
Build Your Own Stevanato Group Narrative
Prefer your own analysis or want to challenge these conclusions? Dive into the numbers and shape your narrative in just a few minutes. Do it your way
A good starting point is our analysis highlighting 2 key rewards investors are optimistic about regarding Stevanato Group.
Looking for More Investment Ideas?
Why settle for ordinary stocks when Simply Wall Street’s screeners can point you to unique opportunities that others might miss? Give yourself an edge this season.
Unlock robust income potential by checking out steady performers among these 17 dividend stocks with yields > 3% offering yields above 3%.
Seize the chance to be early in revolutionary AI trends by tracking these 24 AI penny stocks on the frontier of innovation.
Tap into lucrative opportunities where prices have not caught up by scanning these 873 undervalued stocks based on cash flows based on real cash flow value.